27 subscribers
Player FM uygulamasıyla çevrimdışı Player FM !
Samantha Semenkow - Biotech Valuation in the Public Markets
Manage episode 299458875 series 2788785
Sam Semenkow, Ph.D. is a Director of Portfolio Intelligence at Bridge Bio, a unique biotechnology company that develops drugs in several modalities for a number of diverse disease areas. Prior to joining Bridge Bio, Sam was an Associate in the equity research group at Citi, a multinational bank. As an equity research associate, Sam covered a number of public biotech companies- applying valuations and building financial models for commercial and clinical stage drug candidates. Sam holds a Ph.D from the Johns Hopkins School of Medicine. In this episode, Sam discusses the hiring process for equity research groups for individuals with advanced degrees. She also describes the type of work one would do while working in equity research. We finish the episode with a description of Bridge Bio, and a discussion on assessing risk in biotech.
Hosted by Roshan Chikarmane, Jenna Glatzer, and Joe Varriale.
84 bölüm
Manage episode 299458875 series 2788785
Sam Semenkow, Ph.D. is a Director of Portfolio Intelligence at Bridge Bio, a unique biotechnology company that develops drugs in several modalities for a number of diverse disease areas. Prior to joining Bridge Bio, Sam was an Associate in the equity research group at Citi, a multinational bank. As an equity research associate, Sam covered a number of public biotech companies- applying valuations and building financial models for commercial and clinical stage drug candidates. Sam holds a Ph.D from the Johns Hopkins School of Medicine. In this episode, Sam discusses the hiring process for equity research groups for individuals with advanced degrees. She also describes the type of work one would do while working in equity research. We finish the episode with a description of Bridge Bio, and a discussion on assessing risk in biotech.
Hosted by Roshan Chikarmane, Jenna Glatzer, and Joe Varriale.
84 bölüm
Tüm bölümler
×1 Roivant: Reinventing the Paradigm of Conventional Drug Development 51:27
1 Public Relations and Scientific Communications for Biotechnology with Ignacio Guerrero-Ros 44:24
1 What You Should Know About the Biotech Job Market in 2023 with Carina Clingman 56:31
1 Antibody-Drug Conjugates: Targeting Cancer Where it is Vulnerable with David Dornan of Elevation Oncology 28:53
1 Boston Biotech Series: Standing out in the Competitive Recruiting Process for Early Stage Biotech 29:23
1 Boston Biotech Series: Building a Drug Development Platform on New Biology with Isaac Klein of Dewpoint Therapeutics 38:20
1 Boston Biotech Series: Facilitating Start-up Company Formation with Adam Jenkins of Biolabs 36:26
1 JPM Highlights: What’s Next in ImmunoOncology 59:00
1 Lineage Cell Therapeutics: Building an Allogeneic Cell Transplant Therapy Platform 28:41
1 JPM Highlights: Overcoming Complications in Rare Disease Drug Development 46:34
1 Adrian Rubstein: translating science to business in the Latin American biotech ecosystem 53:45
1 Cyclacel Pharmaceuticals: Interventions for Cell Cycle Abnormalities in Cancer 38:56
1 Melatech: Unlocking Melanin’s Biotech Potential for the Benefit of Society in Earth and Space 47:11
1 Ratio Therapeutics: Math Meets Medicine in the Design of Radiotherapies 43:27
1 Anupam Chakravarty: Building Community in the Graduate Education Landscape 40:24
Player FM'e Hoş Geldiniz!
Player FM şu anda sizin için internetteki yüksek kalitedeki podcast'leri arıyor. En iyi podcast uygulaması ve Android, iPhone ve internet üzerinde çalışıyor. Aboneliklerinizi cihazlar arasında eş zamanlamak için üye olun.